Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts

Somatic Cell and Molecular Genetics

Volumn 23, Issue 2, 1997, Pages 123-133

  Wani, Maqsood A ^a   Denko, Nicholas C ^a   Stambrook, Peter J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE REPRESSION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0030801281     PISSN: 07407750     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02679971     Document Type: Article

References (41)

1. Foulds, L. (1958). The natural history of cancer. J. Chronic. Dis. 8:2-37.
2. Fearon, E.R., and Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell 61:759-767.
3. Thacker, J. (1985). The molecular nature of mutations in cultured cells: A review. Mutation Res. 150:431-442.
4. Wolman, S.R. (1983). Karyotypic progression in human tumors. Cancer Metastasis Rev. 2:257-293.
5. Digweed, M. (1993). Human genetic instability syndromes: Single gene defects with increased risk of cancer. Toxicology Letters 67:259-281.
6. Bronner, C.E., Baker, S.M., Morrison, P.T., Warren, G., Smith, L.G., Lescoe, M.K., Kane, M., Earabina, C., Lipford, J., Lindblom, A., Tannergard, R., Bolag, R.J., Godwin, A.R., Ward, D.C., Nordenskjold, M., Fishel, R., Kolodner, R., and Liskay, R.M. (1994). Mutations in the DNA mismatch repair gene homolog hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261.
7. Fishel, R., Lescoe, M.K., Rao, M.R.S., Copeland, M.G., Jenkins, N.G., Garber, J., Kane, M., and Kolodner, R. (1993). The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1036.
8. Peltomaki, P., Lothe, R.A., Aaltonen, L.A., Pylkkanen, L., Nystrom-Lathi, M., Seruca, R., David, I., Holm, R., Ryberg, D., Haugen, A., Brogger, A., Borresen, A.L., and de la Chapelle, A. (1993). Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 53:5853-5855.
9. Han, H-J., Yanagisawa, A., Kato, Y., Park, J.-G., and Nakamura, Y. (1993). Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res. 53:5087-5089.
10. Mironov, N.M., Aguelon, M.A.-M., Potapova, G.I., Omori, Y., Gorbunov, O.V., Klimenkov, A.A., and Yamasaki, H. (1994). Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res. 54:41-44.
11. Risinger, J.I., Berchuck, A., Kohler, M.F., Watson, P., Lynch, H.T., and Boyd, J. (1993). Genetic instability of microsatellites in endometrial carcinoma. Cancer Res. 53:5100-5103.
12. Gonzalez-Zulueta, M., Ruppert, J.M., Tokino, K., Tsai, Y.C., Spruck, C.H. III, Miyao, N., Nichols, P.W., Heermann, G.G., Horn, T., Steven, K., Summerhayes, I.C., Sidransky, D., and Jones, P.A. (1993). Microsatellite instability in bladder cancer. Cancer Res. 53:5620-5623.
13. Livingstone, L.R., White, A., Sprouse, J., Livanose, E., Jacks, T., and Tlsty, T.D. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
14. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C., and Wahl, G.M. (1992). Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.
15. Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., and Vande Woude, G.F. (1996). Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747.
16. Wani, M.A., Xu, X., and Stambrook, P.J. (1994). Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells. Cancer Res. 54:2504-2508.
17. Denko, N.C., Giaccia, A.J., Stringer, J.R., and Stambrook, P.J. (1994). The human Ha-ras oncogene induces genomic instability within one cell cycle. Proc. Natl. Acad. Sci. U.S.A. 91:5124-5128.
18. Denko, N., Stringer, J., Wani, M., and Stambrook, P.J. (1995). Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-Ras. Somatic Cell and Molecular Genetics 21:241-253.
19. Barbacid, M. (1986). Oncogenes and human cancer: Cause or consequences. Carcinogenesis 7:1037-1042.
20. Barbacid, M. (1987). ras genes. Annu. Rev. Biochem. 56:779-827.
21. Forrester, K.C., Almoguera, C., Itan, K., Grizzle, W.E., and Perucho, M. (1987). Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327:298-303.
22. Corominas, M., Kamino, H., Leon, J., and Pellicer, A. (1989). Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation? Proc. Natl. Acad. Sci. U.S.A. 86:6372-6376.
23. Ahuja, H.G., Foti, A., Bar-Eli, M., and Cline, M.J. (1990). The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 75:1684-1690.
24. Land, H., Parada, L.F., and Weinberg, R.A. (1983). Cellular oncogenes and multistep carcinogenesis. Science 222:771-778.
25. Parada, L.F., Land, H., Weinberg, R.A., Wolf, D., and Rotter, V. (1984). Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation. Nature 312:649-651.
26. Thompson, T.C., Southgate, J., Kitchener, G., and Land, H. (1989). Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56:917-930.
27. Tlsty, T.D., White, A., and Sanchez, J. (1992). Suppression of gene amplification in human cell hybrids. Science 255:1425-1427.
28. Noda, M. (1993). Structures and functions of the Krev-1 transformation suppressor gene and its relatives. Biochem. Biophys. Acta. 1155:97-109.
29. Sakoda, T., Kaibuchi, K., Kishi, K., Kishida, S., Doi, K., Hoshino, M., Hattori, S., and Takai, Y. (1992). smg/rap 1/krev 1 p21 s inhibit the signal pathway to the c-fos promoter/enhancer from c-ki-ras p21 but not c-raf-1 kinase in NIH3T3 cells. Oncogene 7:1705-1711.
30. Su, Z., Austin, V.N., Zimmer, S.G., and Fischer, P.B. (1993). Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras transformed cloned rat embryo fibroblasts cells. Oncogene 8:1211-1219.
31. Sambrook, J., Fritsch, E.F., and Maniatis, T. (eds.). Molecular Cloning: A laboratory manual, New York: Cold Spring Harbor Laboratory press, 1989.
32. Feinberg, A.P., and Vogelstein, B. (1983). A technique for radiolabelling DNA restriction endonuclease fragment to high specific activity. Anal. Biochem. 132:6-13.
33. Tlsty, T.D. (1990). Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. U.S.A. 87:3132-3136.
34. Schimke, R.T. (1984). Gene amplification in cultured animal cells. Cell 37:705-713.
35. Hamkalo, B.A., Farnham, P.J., Johnston, R., and Schimke, R.T. (1985). Ultrastructural features of minute chromosomes in a methotrexate resistant mouse 3T3 cell line. Proc. Natl. Acad. Sci. U.S.A. 82:1126-1130.
36. Marx, J. (1993). Forging a path to the nucleus. Science 260:1588-1590.
37. Feig, L.A. (1993). The many roads that lead to ras. Science 260:767-768.
38. Wright, J.A., Smith, H.S., Watt, F.M., Hancock, M.C., Hudson, D.L., and Stark, G.R. (1990). DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. U.S.A. 87:1791-1795.
39. Lu, K., and Campisi, J. (1992). RAS proteins are essential and selective for the action of insulin like growth factor 1 late in G1 phase of cell cycle in BALB/c murine fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89:3889-3893.
40. Howe, P.H., Dobrowolski, S.F., Reddy, K.B., and Satcey, D.W. (1993). Release from G1 growth arrest by transforming growth factor beta 1 requires cellular ras activity. J. Biol. Chem. 268:21448-21452.
41. Woessner, R.D., Chung, T.D.Y., Hofmann, G.A., Mattern, M.R., Mirabelli, C.K., Drake, F.H., and Johnson, R.K. (1990). Differences between normal and ras transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II. Cancer Res. 50:2901-2908.